Health and Wellness
The company, which made the announcement at the JPM Healthcare Conference in San Francisco, will use the funds to expand its AI-powered Halo Intelligence platform.
The digital pharmacy will sell the newly FDA-approved weight-loss pill nationwide, allowing patients to pay through their insurance or in cash.
Ceribell received breakthrough device designation for its LVO stroke detection monitor, and Naox Technologies secured 510(k) clearance for its in-ear EEG device.
A Mesothelioma Center report finds that more than half of Americans use ChatGPT for medical symptoms, widening a gap between patient reliance on AI and clinician concerns.
The collaboration will allow patients considering the oral GLP-1 therapy to access metabolic care through knownwell’s hybrid model.
Virtual pediatric care company Clarity Pediatrics garners $14.5 million to expand into obesity care.
Next year, AI will move beyond administrative support to become a workflow-integrated tool that drives predictive and proactive care and sees true adoption, according to healthcare leaders.
Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.
The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.
AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.